HIGH LEVEL OF COBLL1, A NOVEL ROR1 BINDING PARTNER, IDENTIFIES CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS WITH MUTATED IGHV

被引：0
|
作者：
Plesingerova, H. [1 ,2 ]
Janovska, P. [3 ]
Shaik, A. [3 ]
Poppova, L. [1 ,2 ]
Libra, A. [4 ]
Plevova, K. [1 ,2 ,3 ]
Machac, J. [5 ]
Slapak, I. [5 ]
Pavlova, S. [1 ,2 ,3 ]
Pospisilova, S. [1 ,2 ]
Bryja, V. [3 ,6 ]
机构：
[1] Cent European Inst Technol, Brno, Czech Republic
[2] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Ctr Mol Biol & Gene Therapy, Brno, Czech Republic
[3] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic
[4] Generi Biotech Sro, Hradec Kralove, Czech Republic
[5] Masaryk Univ, Fac Med, Univ Hosp Brno, Clin Pediat Ear Nose & Throat Dis, Brno, Czech Republic
[6] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P195
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [1] Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia
    Plesingerova, Hana
    Janovska, Pavlina
    Mishra, Archana
    Smyckova, Lucie
    Poppova, Lucie
    Libra, Antonin
    Plevova, Karla
    Ovesna, Petra
    Radova, Lenka
    Doubek, Michael
    Pavlova, Sarka
    Pospisilova, Sarka
    Bryja, Vitezslav
    HAEMATOLOGICA, 2018, 103 (02) : 313 - 324
  • [2] UPREGULATED COBLL1 IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) PATIENTS WITH UNMUTATED IGHV IDENTIFIES A COHORT WITH INFERIOR PROGNOSIS
    Plesingerova, H.
    Janovska, P.
    Poppova, L.
    Shaik, A.
    Jurcickova, Z.
    Libra, A.
    Plevova, K.
    Machac, J.
    Slapak, I.
    Pavlova, S.
    Ovesna, P.
    Kotaskova, J.
    Doubek, M.
    Pospisilova, S.
    Bryja, V.
    HAEMATOLOGICA, 2015, 100 : 50 - 50
  • [3] High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia
    Ghia, Emanuela M.
    Rassenti, Laura Z.
    Choi, Michael Y.
    Quijada-Alamo, Miguel
    Chu, Elvin
    Widhopf, George F., II
    Kipps, Thomas J.
    LEUKEMIA, 2022, 36 (06) : 1609 - 1618
  • [4] High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia
    Emanuela M. Ghia
    Laura Z. Rassenti
    Michael Y. Choi
    Miguel Quijada-Álamo
    Elvin Chu
    George F. Widhopf
    Thomas J. Kipps
    Leukemia, 2022, 36 : 1609 - 1618
  • [5] COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status
    Plesingerova, Hana
    Librova, Zuzana
    Plevova, Karla
    Libra, Antonin
    Tichy, Boris
    Francova, Hana Skuhrova
    Vrbacky, Filip
    Smolej, Lukas
    Mayer, Jiri
    Bryja, Vitezslav
    Doubek, Michael
    Pospisilova, Sarka
    LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 70 - 79
  • [6] High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
    Cui, Bing
    Ghia, Emanuela M.
    Chen, Liguang
    Rassenti, Laura Z.
    DeBoever, Christopher
    Widhopf, George F., II
    Yu, Jian
    Neuberg, Donna S.
    Wierda, William G.
    Rai, Kanti R.
    Kay, Neil E.
    Brown, Jennifer R.
    Jones, Jeffrey A.
    Gribben, John G.
    Frazer, Kelly A.
    Kipps, Thomas J.
    BLOOD, 2016, 128 (25) : 2931 - 2940
  • [7] High-Level Expression of ROR1 Associates with Early Disease Progression in Patients with Chronic Lymphocytic Leukemia
    Cui, Bing
    Chen, Liguang
    Rassenti, Laura Z.
    Ghia, Emanuela M.
    Yu, Jian
    Zhang, Ling
    Neuberg, Donna S.
    Wierda, William
    Keating, Michael
    Rai, Kanti R.
    Kay, Neil E.
    Brown, Jennifer R.
    Byrd, John C.
    Gribben, John
    Kipps, Thomas J.
    BLOOD, 2015, 126 (23)
  • [8] The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
    Hojjat-Farsangi, Mohammad
    Khan, Abdul Salam
    Daneshmanesh, Amir Hossein
    Moshfegh, Ali
    Sandin, Asa
    Mansouri, Ladan
    Palma, Marzia
    Lundin, Jeanette
    Osterborg, Anders
    Mellstedt, Hakan
    PLOS ONE, 2013, 8 (10):
  • [9] Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
    A H Daneshmanesh
    M Hojjat-Farsangi
    A S Khan
    M Jeddi-Tehrani
    M M Akhondi
    A A Bayat
    R Ghods
    A-R Mahmoudi
    R Hadavi
    A Österborg
    F Shokri
    H Rabbani
    H Mellstedt
    Leukemia, 2012, 26 : 1348 - 1355
  • [10] Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
    Daneshmanesh, A. H.
    Hojjat-Farsangi, M.
    Khan, A. S.
    Jeddi-Tehrani, M.
    Akhondi, M. M.
    Bayat, A. A.
    Ghods, R.
    Mahmoudi, A-R
    Hadavi, R.
    Osterborg, A.
    Shokri, F.
    Rabbani, H.
    Mellstedt, H.
    LEUKEMIA, 2012, 26 (06) : 1348 - 1355
12345